Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures

Altar CA, Laeng P, Jurata LW, Brockman JA, Lemire A, Bukhman YV, Young TA, Charles VD, Palfreyman MG. Electroconvulsive seizures regulate the gene expression of distinct neurotrophic signaling pathways. J Neurosci 2004;24:2667–77. Bahn, 2001, Gene expression profiling in the post-mortem human brain—no cause for dismay, J. Chem. Neuroanat., 22, 79, 10.1016/S0891-0618(01)00099-0 Bezchlibnyk, 2001, Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex, J. Neurochem., 79, 826, 10.1046/j.1471-4159.2001.00628.x Borglum, 1999, Two novel variants in the DOPA decarboxylase gene: association with bipolar affective disorder, Mol. Psychiatry, 4, 545, 10.1038/sj.mp.4000559 Borglum, 2001, Dopa decarboxylase genotypes may influence age at onset of schizophrenia, Mol. Psychiatry, 6, 712, 10.1038/sj.mp.4000902 Borglum, 2003, Possible parent-of-origin effect of Dopa decarboxylase in susceptibility to bipolar affective disorder, Am. J. Med. Genet., 117B, 18, 10.1002/ajmg.b.10030 Bowden, 1996, Relation of serum valproate concentration to response in mania, Am. J. Psychiatry, 153, 765, 10.1176/ajp.153.6.765 Bunney, 2003, Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders, Am. J. Psychiatry, 160, 657, 10.1176/appi.ajp.160.4.657 Burns, 2003, Expression profiling analyses of gonadotropin responses and tumor development in the absence of inhibins, Endocrinology, 144, 4492, 10.1210/en.2003-0476 Chuaqui, 2002, Post-analysis follow-up and validation of microarray experiments, Nat. Genet., 32, 509, 10.1038/ng1034 David, 1997, Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion, Nat. Genet., 17, 65, 10.1038/ng0997-65 Feldman, 2002, Advantages of mRNA amplification for microarray analysis, Biotechniques, 33, 906, 10.2144/02334mt04 Garber, 2001, Diversity of gene expression in adenocarcinoma of the lung, Proc. Natl. Acad. Sci. U.S.A., 98, 13784, 10.1073/pnas.241500798 Hakak, 2001, Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia, Proc. Natl. Acad. Sci. U.S.A., 98, 4746, 10.1073/pnas.081071198 Hamajima, 1996, A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution, Gene, 180, 157, 10.1016/S0378-1119(96)00445-3 Hu, 2002, Obtaining reliable information from minute amounts of RNA using cDNA microarrays, BMC Genomics, 3, 16, 10.1186/1471-2164-3-16 Inagaki, 2001, CRMP-2 induces axons in cultured hippocampal neurons, Nat. Neurosci., 4, 781, 10.1038/90476 Johnston-Wilson, 2000, Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium, Mol. Psychiatry, 5, 142, 10.1038/sj.mp.4000696 Joo, 1999, Possible association between schizophrenia and a CAG repeat polymorphism in the spinocerebellar ataxia type 1 (SCA1) gene on human chromosome 6p23, Psychiatry Genet., 9, 7, 10.1097/00041444-199903000-00002 Kothapalli, 2002, Microarray results: how accurate are they?, BMC Bioinformatics, 3, 22, 10.1186/1471-2105-3-22 Kuo, 2002, Analysis of matched mRNA measurements from two different microarray technologies, Bioinformatics, 18, 405, 10.1093/bioinformatics/18.3.405 Kuromitsu, 2001, Reduced neuropeptide Y mRNA levels in the frontal cortex of people with schizophrenia and bipolar disorder, Gene Exp. Patterns, 1, 17, 10.1016/S1567-133X(01)00003-5 Li, 2004, Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions, Hum. Mol. Genet., 13, 609, 10.1093/hmg/ddh065 Lockhart, 1996, Expression monitoring by hybridization to high-density oligonucleotide arrays, Nat. Biotechnol., 14, 1675, 10.1038/nbt1296-1675 Middleton, 2002, Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia, J. Neurosci., 22, 2718, 10.1523/JNEUROSCI.22-07-02718.2002 Mirnics, 2000, Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex, Neuron, 28, 53, 10.1016/S0896-6273(00)00085-4 Nadon, 2002, Statistical issues with microarrays: processing and analysis, Trends Genet., 18, 265, 10.1016/S0168-9525(02)02665-3 Nisenbaum, 2002, The ultimate chip shot: can microarray technology deliver for neuroscience?, Genes Brain Behav., 1, 27, 10.1046/j.1601-1848.2001.00013.x Nishizuka, 2003, Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays, Proc. Natl. Acad. Sci. U.S.A., 100, 14229, 10.1073/pnas.2331323100 Palfreyman, 2002, Novel directions in antipsychotic target identification using gene arrays, Curr. Drug Targets: CNS Neurol. Disorders, 1, 205, 10.2174/1568007024606203 Perou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038/35021093 Pope, 1991, Valproate in the treatment of acute mania, Arch. Gen. Psychiatry, 48, 62, 10.1001/archpsyc.1991.01810250064008 Puskas, 2002, Production of bulk amounts of universal RNA for DNA microarrays, Biotechniques, 33, 898, 10.2144/02334mt03 Quackenbush, 2002, Microarray data normalization and transformation, Nat. Genet., 32, 496, 10.1038/ng1032 Rajeevan, 2001, Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies, Methods, 25, 443, 10.1006/meth.2001.1266 Reith, 1994, Elevated dopa decarboxylase activity in living brain of patients with psychosis, Proc. Natl. Acad. Sci. U.S.A., 91, 11651, 10.1073/pnas.91.24.11651 Rhodes, 2002, Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer, Cancer Res., 62, 4427 Rychlik, 1995, Selection of primers for polymerase chain reaction, Mol. Biotechnol., 3, 129, 10.1007/BF02789108 Schena, 1995, Quantitative monitoring of gene expression patterns with a complementary DNA microarray, Science, 270, 467, 10.1126/science.270.5235.467 Sterrenburg, 2002, A common reference for cDNA microarray hybridizations, Nucleic Acids Res., 30, e116, 10.1093/nar/gnf115 Tan, 2003, Evaluation of gene expression measurements from commercial microarray platforms, Nucleic Acids Res., 31, 5676, 10.1093/nar/gkg763 Tashiro, 1999, An autopsy case of spinocerebellar ataxia type 6 with mental symptoms of schizophrenia and dementia, Clin. Neuropathol., 18, 198 Torrey, 2000, The Stanley Foundation brain collection and neuropathology consortium, Schizophr. Res., 44, 151, 10.1016/S0920-9964(99)00192-9 Vawter, 2001, Application of cDNA microarrays to examine gene expression differences in schizophrenia, Brain Res. Bull., 55, 641, 10.1016/S0361-9230(01)00522-6 Vincent, 2000, Long repeat tracts at SCA8 in major psychosis, Am. J. Med. Genet., 96, 873, 10.1002/1096-8628(20001204)96:6<873::AID-AJMG37>3.0.CO;2-9 Walker, 2002, Tech. sight. A technique whose time has come, Science, 296, 557, 10.1126/science.296.5567.557 Wei, 1996, A study of the relationship between the DBH activity in serum and a MspI polymorphic site in intron 9 of the human DBH gene in schizophrenia, Schizophr. Res., 22, 77, 10.1016/0920-9964(96)00064-3 Wei, 1997, Is the polymorphic microsatellite repeat of the dopamine beta-hydroxylase gene associated with biochemical variability of the catecholamine pathway in schizophrenia?, Biol. Psychiatry, 41, 762, 10.1016/S0006-3223(96)00218-1 Williams NM, O’Donovan MC, Owen MJ. Genome scans and microarrays: converging on genes for schizophrenia? Genome Biol 2002;3:REVIEWS1011. Yamamoto, 2003, Dopamine beta-hydroxylase (DBH) gene and schizophrenia phenotypic variability: a genetic association study, Am. J. Med. Genet., 117B, 33, 10.1002/ajmg.b.10011 Yang IV, Chen E, Hasseman JP, Liang W, Frank BC, Wang S, Sharov V, Saeed AI, White J, Li J, Lee NH, Yeatman TJ, Quackenbush J. Within the fold: assessing differential expression measures and reproducibility in microarray assays. Genome Biol 2002;3:research0062.1–12. Yoo, 2003, SCA7 knockin mice model human SCA7 and reveal gradual accumulation of mutant ataxin-7 in neurons and abnormalities in short-term plasticity, Neuron, 37, 383, 10.1016/S0896-6273(02)01190-X Yue H, Eastman PS, Wang BB, Minor J, Doctolero MH, Nuttall RL, Stack R, Becker JW, Montgomery J.R, Vainer M, Johnston R. An evaluation of the performance of cDNA microarrays for detecting changes in global mRNA expression. Nucleic Acids Res 2001;29:E41–1. Yuen, 2002, Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays, Nucleic Acids Res., 30, e48, 10.1093/nar/30.10.e48 Zander, 2001, Similarities between spinocerebellar ataxia type 7 (SCA7) cell models and human brain: proteins recruited in inclusions and activation of caspase-3a, Hum. Mol. Genet., 10, 2569, 10.1093/hmg/10.22.2569 Zhao, 2002, Optimization and evaluation of T7 based RNA linear amplification protocols for cDNA microarray analysis, BMC Genomics, 3, 31, 10.1186/1471-2164-3-31